BackFennec Pharmaceuticals Overview
Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Target Price

See Fennec Pharmaceuticals's analyst price targets ($16) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.2

Average Target Price

$16.0056.9% upside

1 analysts in the last 4 months

High: $16 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-12Wedbush$1656.9% upsideOpen
2026-05-22H.C. Wainwright$1656.9% upsideOpen
2026-01-08Piper Sandler$1876.5% upsideOpen
2025-08-15Craig-HallumChase Knickerbocker$1437.3% upsideOpen
2024-05-15Craig-HallumChase Knickerbocker$1766.7% upsideOpen
2024-05-15H.C. WainwrightRaghuram Selvaraju$1547.1% upsideOpen
2024-04-04H.C. WainwrightRaghuram Selvaraju$1876.5% upsideOpen
2024-03-19Craig-HallumChase Knickerbocker$1876.5% upsideOpen
2022-11-22Cantor Fitzgerald$1217.6% upsideOpen
2022-09-26Wedbush$1986.3% upsideOpen

Fennec Pharmaceuticals (FENC) FAQ

As of the most recent data, FENC shows a target price of $16. Scroll down for historical charts and peer comparison views.

If Fennec Pharmaceuticals moved to the average analyst target of $16, shares would be roughly 56.9% higher than $10.2. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Fennec Pharmaceuticals's earnings trajectory.

Besides this target price page, Stockcircle has Fennec Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $16) with ownership activity and broader fundamentals.

Fennec Pharmaceuticals's target price is $16; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.